RNAi in Neurodegenerative Diseases—What's the Therapeutic Potential?

18 Mar 2003

Strobel Thanks, Claudius, and yes, let's move to targets in Alzheimer's disease. Let me put out

Cholinergic Plasticity in Hippocampus of Individuals with Mild Cognitive Impairment: Correlation with Alzheimer's Neuropathology

19 May 2003

in the Journal of Alzheimer's Disease, which is making the full text (.pdf) of these papers

Therapeutic Nihilism: Widespread Yet Passé? AD Acetylcholinesterase Inhibitors Are Better Than Their Reputation

14 Oct 2003

Alzheimer's elephant and trying to determine how the drugs were affecting it. I think with recent studies,

Novel Substrates for BACE1 Beg the Question: What's the Biological Function of β-Secretase?

17 Dec 2003

organizing the chat. In a year's time, we will likely have more substrates and can better judge the

Clioquinol Trial Postmortem: Does Blocking Metal-Aβ Interactions Work?

15 Jan 2004

Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci. 1998 Jun

Minority Views and Professional Responsibilities—Scientists Air Their Views

10 Mar 2004

bottom of the page. Transcript unavailable. Background Text By Gabrielle Strobel and Tom Fagan   As

Stem Cell Therapies for Neurodegenerative Disease: How Should We Push Ahead?

30 Mar 2004

a cell that has the capability of self-renewing over a prolonged time period and can generate multiple

Vascular Factors in Alzheimer's Disease

21 Apr 2004

Hippocampal sclerosis is a common age-related pathology seen with Alzheimer's disease and vascular

Protein Misfolding: An Unfolding Series of Discussions

09 Jun 2004

diseases? Maria Figueiredo Pereira I think that misfolded proteins are produced all the time and the

Cast Call for Players: Healthy Aging Through Lean Living

17 Aug 2004

oxidative damage thought to participate in neurodegenerative diseases such Alzheimer's and

Memantine: Implications for Treating Alzheimer's

29 Sep 2004

Alzheimer's Association and the Alzheimer Research Forum. Participants: Antonio Alvarez, caregiver; Steven T.

Role and Control of Metal-Mediated Fibril Toxicity

20 Dec 2004

David Allsop and Ashley Bush led this live discussion on 20 December 2004. Readers are invited to

What Price Privacy? Is the HIPAA Law Stifling Dementia Research?

24 Apr 2005

a hindrance to what should be everyone's overarching goal: Understanding and treating Alzheimer

Imaging in Alzheimer's Disease: The Current State of Affairs

27 Apr 2005

between the initial rate of uptake of PIB and late-time distribution in AD subjects. Hank F. Kung Chet,

Making a BioMark on Alzheimer Disease

01 Jun 2005

biomarker modalities in middle-aged folks and then following them over time. I'm working with Dr.